The University of Chicago Header Logo

Connection

Adam DuVall to CD47 Antigen

Back to Details
This is a "connection" page, showing publications Adam DuVall has written about CD47 Antigen.
Adam DuVall
Connection Strength
0.232
CD47 Antigen
  1. Treatment outcomes of venetoclax-combination regimens for relapsed/refractory myeloid malignancies after anti-CD47-directed therapy. Leuk Lymphoma. 2024 Jun; 65(6):864-867.
    View in: PubMed
    Score: 0.232
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.